Table 1

The number of double positive CCR9/CD14 cells in rheumatoid and non-rheumatoid synovial tissue

Patient

Number of CCR9+ cells

(mean ± SE)

Number of CD14+ cells

(mean ± SE)

Number of CCR9+/CD14+ cells

(mean ± SE)

Rheumatoid

1 (n = 92)

25 ±10

36 ± 9

25 ± 10

2 (n = 91)

59 ± 23

45 ± 25

43 ± 24

3 (n = 137)

64 ± 20

64 ± 20

51 ±12

4 (n = 136)

60 ± 10

60 ± 13

59 ± 12

5 (n = 173)

65 ± 23

80 ± 35

62 ± 24

6 (n = 166)

106 ± 9

135 ± 11

104 ± 9

Overall mean ± SE

63 ± 10

70 ± 14

57 ± 11

Non-rheumatoid

1 (n = 76)

38 ± 12

1 ± 1

1 ± 1

2 (n = 77)

5 ± 5

4 ± 3

3 ± 3

3 (n = 70)

9 ± 4

4 ± 6

4 ± 6

4 (n = 47)

5 ± 1

5 ± 2

4 ± 3

5 (n = 75)

5 ± 3

11 ± 4

5 ± 4

6 (n = 75)

10 ± 3

10 ± 2

7 ± 2

Overall mean ± SE

12 ± 5

6 ± 2

4 ± 1

The data are mean numbers of positive cells (± standard error) per field of view; n = mean number of total cells sampled per field of view as assessed by counting the numbers of nuclei stained by DAPI.

Schmutz et al. Arthritis Research & Therapy 2010 12:R161   doi:10.1186/ar3120